NEW YORK — Nucleic acid manufacturer DNA Script said on Thursday that it has received $1.6 million from the French Defense Innovation Agency to build a prototype qPCR probe manufacturing platform that can be used in the rapid development of biothreat diagnostics.
DNA Script said it will adapt its Syntax benchtop DNA printer for the rapid synthesis of DNA reagents such as Taqman probes that can be used to develop tests for the detection of pathogenic viruses and bacteria. The prototype will then be evaluated by the French Armament General Directorate.